Camurus AB
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-05-12
Analyst
SEB
Equibles does not estimate personal net worth.
Christoffer Ude is recorded as Analyst at SEB. Christoffer Ude has spoken on 1 earnings call across 1 company, most recently for Camurus AB on May 12, 2026. The companies whose calls Christoffer Ude spoke on are classified in the Healthcare sector.
“Yeah, Molly, if you wouldn't mind, I was wondering about, so there was an article in the San Francisco Chronicle a little recently discussing brixadi and sublocate and the importance of initiating at the correct dose and talking about patients who refused a second dose after experiencing withdrawal, I guess, triggered…”
SEB
Analyst
Transcript header (unverified)
Camurus AB
Biotechnology · Healthcare
Camurus’ Interim Report January-March 2026
Camurus AB